Verdiva Bio is committed to developing next-generation therapies to help people living with obesity, cardiometabolic disorders, and related complications achieve better outcomes via more patient-friendly therapeutic options.
Location: United States
Total raised: $1.02B
Investors 1
| Date | Name | Website |
| 19.05.2025 | Forbion | forbion.co... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 11.09.2025 | Series B | $611.07M | - |
| 13.01.2025 | Series A | $411M | - |
Mentions in press and media 21
| Date | Title | Description |
| 26.02.2026 | Revolut: Digital Powerhouse Redefines Global Finance Amidst Regulatory Scrutiny | Revolut, the UK fintech titan, achieved a $75 billion valuation in 2025, disrupting traditional banking. Global expansion remains a priority, marked by a Mexico banking launch. However, a full UK banking license still eludes the firm, amids... |
| 06.02.2026 | From big rounds to broad momentum: the UK tech ecosystem | In 2025, the UK led European tech investment by a wide margin, raising €21.5 billion across 830 deals and topping investment volumes in every quarter of the year. Funding was driven by a small number of very large transactions alongside a b... |
| 15.01.2026 | UK VC Investment Rebounds in 2025 | UK startups and scaleups raised $23.6 billion in venture capital funding in 2025, a 35% increase on 2024 and the first annual growth in UK VC investment in four years, according to new analysis from HSBC Innovation Banking UK and Dealroom. ... |
| 10.01.2026 | 2026 is the year of obesity pills. Here’s how they could reshape the GLP-1 market | In 2026, new obesity pills will push the booming GLP-1 market into its next chapter. Pills may serve as a more convenient — and in certain cases cheaper — alternative to today’s blockbuster injections that could attract entirely new patient... |
| 15.09.2025 | Europe's VC Shift: UK Fights for Lead as Healthtech Soars in 2025 | European venture capital is undergoing significant shifts in 2025. The UK remains a leader, but emerging competition from Germany and France is notable. Healthtech and AI innovation are major investment drivers, securing billions across the... |
| 11.09.2025 | Europe's 10 biggest healthtech deals in H1 2025 | Healthtech continued to demonstrate its strength in Europe in the first half of 2025, attracting €4 billion in funding, around 12 per cent of the €33.7 billion raised across all European tech sectors. Although healthtech accounted for just ... |
| 23.04.2025 | The Surge of Innovation: Healthtech and Energy Solutions in Europe | In the heart of Europe, a financial storm is brewing. The healthtech and AI sectors are not just weathering the global economic climate; they are thriving. In the first quarter of 2025, European healthtech and AI startups raised a staggerin... |
| 22.04.2025 | Europe’s healthtech and AI startups raise $13.9B in Q1 as global investors return | Q1 data from Dealroom reveals that European health tech and AI companies continue to attract significant interest from global venture capital investors, with $13.9 billion raised in the first quarter of 2025. This represents a 2 per cent ye... |
| 17.04.2025 | London startups bag £2.69bn in VC funding in 2025 so far | London-based startups attracted £2.69bn in venture capital (VC) in the first three months of the year, marking a robust start of the year despite a fall in deal volumes. According to KPMG’s latest venture pulse report, while deal count drop... |
| 14.04.2025 | UK surges ahead of France and Germany as Europe’s ‘innovation powerhouse’ | HSBC Innovation Banking, a subsidiary of Europe’s biggest lender, hailed the UK’s enterprise value in its latest innovation report. UK innovation firms raised £3.2bn of venture capital in the first three months of the year – an eight per ce... |
Show more